Legis Daily

Improving Low-Income Access to Prescription Drugs Act of 2019

USA116th CongressHR-3029| House 
| Updated: 6/4/2019
Pete Olson

Pete Olson

Republican Representative

Texas

Cosponsors (3)
Kenny Marchant (Republican)John Lewis (Democratic)Nanette Diaz Barragán (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Improving Low-Income Access to Prescription Drugs Act of 2019 This bill provides statutory authority for the Centers for Medicare & Medicaid Services transition program under the Medicare prescription drug benefit for limited-income, newly eligible individuals (i.e., individuals who are eligible for subsidies and have not yet enrolled in, or whose coverage has not yet taken effect under, a Medicare or Medicare Advantage prescription drug plan). The program's coverage provides immediate access to covered drugs at the point of sale as soon as the individual becomes eligible for subsidies; coverage also applies retroactively for dual eligible individuals and for individuals who receive benefits under the Supplemental Security Income program.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 28, 2019
Introduced in House
May 28, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 29, 2019
Referred to the Subcommittee on Health.
Jun 4, 2019
Subcommittee Hearings Held.
Jun 27, 2019

Latest Companion Bill Action

S 116-1999
Introduced in Senate
  • May 28, 2019
    Introduced in House


  • May 28, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 29, 2019
    Referred to the Subcommittee on Health.


  • June 4, 2019
    Subcommittee Hearings Held.


  • June 27, 2019

    Latest Companion Bill Action

    S 116-1999
    Introduced in Senate

Health

Related Bills

  • S 116-2543: Prescription Drug Pricing Reduction Act of 2019
  • S 116-3129: Lower Costs, More Cures Act of 2019
  • HR 116-3417: BETTER Act of 2019
  • S 116-1999: Improving Low Income Access to Prescription Drugs Act of 2019
  • S 116-4199: Prescription Drug Pricing Reduction Act of 2020
  • HR 116-19: Lower Costs, More Cures Act of 2019
Health care coverage and accessMedicarePoverty and welfare assistancePrescription drugs

Improving Low-Income Access to Prescription Drugs Act of 2019

USA116th CongressHR-3029| House 
| Updated: 6/4/2019
Improving Low-Income Access to Prescription Drugs Act of 2019 This bill provides statutory authority for the Centers for Medicare & Medicaid Services transition program under the Medicare prescription drug benefit for limited-income, newly eligible individuals (i.e., individuals who are eligible for subsidies and have not yet enrolled in, or whose coverage has not yet taken effect under, a Medicare or Medicare Advantage prescription drug plan). The program's coverage provides immediate access to covered drugs at the point of sale as soon as the individual becomes eligible for subsidies; coverage also applies retroactively for dual eligible individuals and for individuals who receive benefits under the Supplemental Security Income program.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 28, 2019
Introduced in House
May 28, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 29, 2019
Referred to the Subcommittee on Health.
Jun 4, 2019
Subcommittee Hearings Held.
Jun 27, 2019

Latest Companion Bill Action

S 116-1999
Introduced in Senate
  • May 28, 2019
    Introduced in House


  • May 28, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 29, 2019
    Referred to the Subcommittee on Health.


  • June 4, 2019
    Subcommittee Hearings Held.


  • June 27, 2019

    Latest Companion Bill Action

    S 116-1999
    Introduced in Senate
Pete Olson

Pete Olson

Republican Representative

Texas

Cosponsors (3)
Kenny Marchant (Republican)John Lewis (Democratic)Nanette Diaz Barragán (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-2543: Prescription Drug Pricing Reduction Act of 2019
  • S 116-3129: Lower Costs, More Cures Act of 2019
  • HR 116-3417: BETTER Act of 2019
  • S 116-1999: Improving Low Income Access to Prescription Drugs Act of 2019
  • S 116-4199: Prescription Drug Pricing Reduction Act of 2020
  • HR 116-19: Lower Costs, More Cures Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health care coverage and accessMedicarePoverty and welfare assistancePrescription drugs